Researchers Shed Light on How to Predict Which Skin Cancer Patients Are Most Likely to Respond to Immunotherapy Jan. 8, 2025 — An international team of UK and US scientists discovered that the ...
It turns out that two of these microbially-modified bile acids may affect ... Unlocking the Secrets of Cancer Metastasis: Study Provides New Insights, Potential Therapeutic Opportunities Oct.
A phase II trial found that T-VEC improved tumor resectability in 50% of patients, leading to early study discontinuation, with strong immune response activation and minimal side effects.